Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells

Leuk Res. 2004 Jun;28(6):623-9. doi: 10.1016/j.leukres.2003.10.022.

Abstract

Bcr-Abl tyrosine kinase inhibitor induces apoptosis and erythroid differentiation of K562 cells. During this erythroid differentiation, c-Myc and cyclin D1 transcripts are transiently downregulated. Accordingly, we studied the effect of cyclin D1 overexpression on erythroid differentiation. After treatment with 250 nM STI571, 90% of K562 and 25% of K562/D1 cells underwent erythroid differentiation. The basal expression of glycophorin A in K562/D1 cells was markedly diminished compared with that by parental cells. STI571 treatment failed to induce glycophorin A expression in K562/D1 cells. During STI571 treatment, ERK activity was downregulated in parental cells, while it was constantly activated in K562/D1 cells. These results suggest that ectopic expression of cyclin D1 causes the resistance of K562 cells to erythroid differentiation by modulating ERK regulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzamides
  • Benzoquinones
  • Cell Differentiation / drug effects*
  • Cyclin D1 / metabolism*
  • Down-Regulation
  • Drug Resistance, Neoplasm
  • Enzyme Inhibitors / pharmacology*
  • Erythroid Precursor Cells / drug effects*
  • Erythroid Precursor Cells / pathology
  • Glycophorins / metabolism
  • Humans
  • Imatinib Mesylate
  • K562 Cells
  • Lactams, Macrocyclic
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinase Kinases / metabolism
  • Mitogen-Activated Protein Kinases / metabolism
  • Phosphorylation
  • Piperazines / pharmacology*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrimidines / pharmacology*
  • Quinones / pharmacology
  • Rifabutin / analogs & derivatives
  • Signal Transduction
  • Transfection

Substances

  • Benzamides
  • Benzoquinones
  • Enzyme Inhibitors
  • Glycophorins
  • Lactams, Macrocyclic
  • Piperazines
  • Pyrimidines
  • Quinones
  • Cyclin D1
  • Rifabutin
  • herbimycin
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinase Kinases